FDA: Deregulating During The Pandemic, And Beyond – OpEd

The press has obsessively focused on supposed government shortfalls regarding COVID-19 testing. However, virtually no attention has been given to the Food and Drug Administration’s (FDA’s) vigorous and unprecedented efforts to ease regulatory requirements during the pandemic.

One such effort involves “immediately in...